Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

The CTSA Program Collaborative and Innovative Acceleration Award is a funding opportunity aimed at supporting the development and dissemination of innovative solutions to improve the efficiency of translational science, through collaboration among CTSA Program hubs, NIH Institutes, Centers, Offices and external stakeholders.

$650,000

Closed

Nationwide

Grant Description

The Clinical and Translational Science Award (CTSA) Program Collaborative and Innovative Acceleration Award (CCIA) supports synergistic activities that accelerate the translational research process through collaboration and innovation. This funding opportunity announcement (FOA) invites applications to develop, demonstrate and disseminate innovative solutions to transform the field of translational science by addressing the inefficiencies that are common across diseases and bringing more interventions to all people more quickly through collaborative science among the CTSA Program hubs, NIH Institutes, Centers, Offices (ICOs) and/or external stakeholders.

Funding Details

Award Range

Not specified - $650,000

Total Program Funding

$6,000,000

Number of Awards

Not specified

Matching Requirement

Eligibility

Eligible Applicants

Public and State controlled institutions of higher education

Additional Requirements

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Geographic Eligibility

All

Key Dates

Application Opens

May 9, 2022

Application Closes

October 17, 2024

Contact Information

Grantor

NIH OER Webmaster

OERWebmaster03@od.nih.gov

Subscribe to view contact details

Newsletter Required